Clinical Evidence: How Do These Treatments Compare?
Wegovy Comparison: Understanding Clinical Trial Weight Loss Results
When evaluating a Wegovy comparison for weight management, the STEP clinical trial programme provides the most comprehensive evidence base available. In the landmark STEP 1 trial, published by Wilding et al. in the New England Journal of Medicine (2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. This represents one of the most robust datasets in modern obesity medicine, with over 1,900 participants followed for more than a year.
The sustained nature of these results sets Wegovy apart in any weight loss comparison. STEP 5 demonstrated that participants maintained approximately clinically studied weight loss at the two-year mark, whilst the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events. These findings position Wegovy not just as a weight management tool, but as a treatment that may support broader health improvements when used as part of a comprehensive lifestyle approach.
Wegovy Comparison Pricing: UK Treatment Costs Breakdown
Understanding the financial commitment is crucial in any Wegovy comparison with alternative treatments. At EverydayMeds, Wegovy pricing follows the dose escalation schedule: 0.25mg starter dose costs £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose (£209.99). New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Our bundle options provide convenient multi-month supply options for those committed to their weight management journey. The Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first three months of dose escalation. For maintenance phase stability, the Ultimate Stability Trio provides three 2.4mg pens for £649.99. These bundles ensure uninterrupted treatment supply whilst reducing the frequency of orders and deliveries.
Wegovy vs Mounjaro: Weight Loss Results Comparison
In any comprehensive Wegovy comparison, Mounjaro (tirzepatide) represents the most relevant alternative treatment. While both have demonstrated significant weight loss outcomes, direct comparison of trial percentages isn't appropriate due to different study designs, participant populations, and endpoints. Wegovy works as a GLP-1 receptor agonist, whilst Mounjaro functions as a dual GIP and GLP-1 receptor agonist, representing distinct mechanisms of action.
The practical differences extend beyond mechanisms to storage requirements and dosing schedules. Wegovy offers superior storage flexibility, remaining stable at room temperature for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. Both treatments require weekly injections and gradual dose escalation, but the specific timing and increments differ between the two options.
How Wegovy Works: The Science Behind Weight Loss Results
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines when you eat. This mechanism targets the brain's appetite centres, specifically the hypothalamus, to promote feelings of fullness after smaller meals and reduce overall food cravings. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Unlike stimulant-based appetite suppressants, Wegovy works through natural hormone pathways that regulate hunger and satiety. This physiological approach explains why clinical trials have shown sustained weight loss outcomes when the treatment is combined with reduced-calorie diet and increased physical activity.
EverydayMeds Wegovy Ordering Process: Simple Assessment to Delivery
Our streamlined process makes accessing Wegovy straightforward, whether you're new to weight management treatments or switching from another option. The initial step involves a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review your assessment within three working days (or 24 hours with express service), ensuring clinical suitability before approving treatment. Once approved, we dispatch your Wegovy via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. All orders are processed through our GPhC-registered pharmacy (#9012878), ensuring compliance with UK pharmaceutical regulations. This entire process eliminates the need for multiple GP appointments whilst maintaining clinical safety standards.
Wegovy Storage and Practical Considerations for UK Users
Proper storage significantly impacts treatment success, making this a key factor in any Wegovy comparison with alternatives. Wegovy requires refrigeration at 2-8°C before first use, but offers exceptional flexibility once removed from the fridge, remaining stable at room temperature (below 30°C) for up to six weeks. The FlexTouch pen design simplifies weekly injections, with clear dose windows and intuitive operation that most patients master quickly. Dose escalation follows a mandatory schedule over 16 weeks, starting at 0.25mg and increasing monthly to reach the 2.4mg maintenance dose. This gradual increase minimises side effects whilst allowing your body to adapt to the medication's effects. The pen design includes safety features to prevent accidental needle exposure and dose errors.
UK-Specific Weight Loss Results: Real-World Wegovy Comparison Data
Beyond clinical trials, real-world evidence from UK patients provides valuable insights for any Wegovy comparison evaluation. Post-market surveillance data suggests that UK patients achieve weight loss outcomes consistent with clinical trial findings when treatment includes appropriate dietary modification and exercise support. The NICE TA875 recommendation specifically requires specialist weight management support alongside Wegovy treatment, recognising that optimal results depend on comprehensive lifestyle intervention.
Regional factors affecting UK results include NHS weight management service availability and cultural dietary patterns that may influence individual responses. EverydayMeds patients benefit from ongoing prescriber support throughout their treatment journey, with regular assessment opportunities to optimise dosing and address any concerns that arise during treatment progression.
Making Your Wegovy Comparison Decision: Next Steps
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your individual circumstances, medical history, and weight management objectives. Our clinical team considers factors including your current medications, storage preferences, injection frequency tolerance, and cost considerations when making treatment recommendations. Remember that both treatments are prescription-only medicines requiring ongoing medical supervision and should be used alongside a reduced-calorie diet and increased physical activity. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy using discount code FIRST40 for new customers, and take the first step towards evidence-based weight management with the support of our GPhC-registered clinical team (#9012878).
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
